Site Announcement
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
| Date | Form | Description | Docs | XBRL | Pages |
| 11/13/26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
8 | |
| 11/13/26 | 8-K | Current report |
|
|
8 |
| 11/12/26 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
|
39 |
| 11/12/26 | SCHEDULE 13G/A | Statement of Beneficial Ownership by Certain Investors |
|
5 | |
| 09/23/26 | 8-K | Current report |
|
|
31 |
| 09/18/26 | SCHEDULE 13G | Statement of Beneficial Ownership by Certain Investors |
|
5 | |
| 09/16/26 | 8-K | Current report |
|
|
194 |
| 08/07/26 | 8-K | Current report |
|
|
6 |
| 08/06/26 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
|
21 |
| 05/29/26 | SCHEDULE 13G | Statement of Beneficial Ownership by Certain Investors |
|
5 |
